Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma

Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma

Abstract In this study, we have surface-functionalized PEGylated-nanoliposomal doxorubicin (DOX) with anti-EpCAM (epithelial cell adhesion molecule) aptamer via post-insertion of anti-EpCAM aptamer-conjugated DSPE-mPEG2000 into Caelyx® (ED-lip). The size, charge, release profile, and cytotoxicity an...

Full description

Bibliographic Details
Main Authors: Mohammad Mashreghi, Parvin Zamani, Seyedeh Alia Moosavian, Mahmoud Reza Jaafari
Format: Article
Language:English
Published: SpringerOpen 2020-05-01
Series:Nanoscale Research Letters
Subjects:
EpCAM
Aptamer
Liposomes
Doxorubicin
Colon cancer
Online Access:http://link.springer.com/article/10.1186/s11671-020-03334-9

Internet

http://link.springer.com/article/10.1186/s11671-020-03334-9

Similar Items